Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $10.69 Average Price Target from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been given an average recommendation of “Hold” by the eleven analysts that are currently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $10.6875.

AVAH has been the topic of a number of research analyst reports. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. Truist Financial increased their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating for the company. Finally, BMO Capital Markets assumed coverage on shares of Aveanna Healthcare in a report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price objective on the stock.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder Paul R. Vigano sold 1,500,000 shares of the business’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the sale, the insider directly owned 362,746 shares in the company, valued at $3,264,714. The trade was a 80.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the company’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider directly owned 362,746 shares of the company’s stock, valued at $3,264,714. This represents a 80.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,597,968 shares of company stock valued at $293,381,712 in the last 90 days. 7.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds have recently made changes to their positions in the business. Banque Transatlantique SA acquired a new stake in Aveanna Healthcare in the 1st quarter valued at $25,000. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare in the 2nd quarter valued at about $43,000. Lion Street Advisors LLC acquired a new stake in shares of Aveanna Healthcare in the third quarter valued at about $89,000. Jump Financial LLC bought a new stake in Aveanna Healthcare during the first quarter worth about $59,000. Finally, Diversified Trust Co bought a new position in Aveanna Healthcare in the second quarter valued at approximately $57,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Trading Down 1.0%

AVAH opened at $8.62 on Wednesday. The firm’s fifty day moving average is $9.07 and its two-hundred day moving average is $7.41. The firm has a market cap of $1.80 billion, a PE ratio of 23.94 and a beta of 2.04. Aveanna Healthcare has a twelve month low of $3.67 and a twelve month high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Equities research analysts anticipate that Aveanna Healthcare will post -0.06 EPS for the current year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.